Shanghai exchange eases rules for biopharmas listing on new innovation board

Revised rules for a new science and technology board loosen requirements for biopharma and tech companies seeking to list on the Shanghai Stock Exchange.

Implemented March 1, the rules update draft rules released Jan. 29 that included five sets of financial criteria for listing on the new board and cut the amount of time it takes to list in Shanghai (see "Shanghai Exchange's Proposed Innovation Board Includes Preprofit Option")...